deltatrials

Myelodysplastic syndromes Trials in Minneapolis, United States

Conditions / Myelodysplastic syndromes / Minneapolis, United States

Myelodysplastic syndromes is a medical condition with active clinical research programs worldwide.

50 total trials for this combination

Showing top 10 of 50 trials

Trials

NCT ID Title Status Phase
NCT06001385 HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis ACTIVE_NOT_RECRUITING PHASE2
NCT00321932 Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant COMPLETED PHASE2
NCT00309842 Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases COMPLETED PHASE2
NCT00028899 Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes COMPLETED PHASE1
NCT03904134 Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) COMPLETED NA
NCT00003793 Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma COMPLETED
NCT00003593 Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome COMPLETED PHASE3
NCT00602446 Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant TERMINATED PHASE2
NCT00516503 Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer COMPLETED PHASE3
NCT00719563 American Ginseng in Treating Patients With Fatigue Caused by Cancer COMPLETED PHASE3

Related Pages